Wang Huixia, Hu Wanhui, Xu Tiandan, Yuan Ya, Liu Dongsheng, Wüthrich Kurt
IHuman Institute, ShanghaiTech University, Shanghai 201210, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
iScience. 2023 May 19;26(6):106918. doi: 10.1016/j.isci.2023.106918. eCollection 2023 Jun 16.
Crystal and cryo-EM structures of the glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) bound with their peptide ligands have been obtained with full-length constructs, indicating that the extracellular domain (ECD) is indispensable for specific ligand binding. This article complements these data with studies of ligand recognition of the two receptors in solution. Paramagnetic NMR relaxation enhancement measurements using dual labeling with fluorine-19 probes on the receptor and nitroxide spin labels on the peptide ligands provided new insights. The glucagon-like peptide-1 (GLP-1) was found to interact with GLP-1R by selective binding to the extracellular surface. The ligand selectivity toward the extracellular surface of the receptor was preserved in the transmembrane domain (TMD) devoid of the ECD. The dual labeling approach further provided evidence of cross-reactivity of GLP-1R and GCGR with glucagon and GLP-1, respectively, which is of interest in the context of medical treatments using combinations of the two polypeptides.
已通过全长构建体获得了与肽配体结合的胰高血糖素样肽-1受体(GLP-1R)和胰高血糖素受体(GCGR)的晶体结构和冷冻电镜结构,这表明细胞外结构域(ECD)对于特异性配体结合必不可少。本文通过对溶液中两种受体的配体识别研究对这些数据进行了补充。使用受体上的氟-19探针和肽配体上的氮氧化物自旋标记进行双标记的顺磁核磁共振弛豫增强测量提供了新的见解。发现胰高血糖素样肽-1(GLP-1)通过选择性结合细胞外表面与GLP-1R相互作用。在没有ECD的跨膜结构域(TMD)中保留了配体对受体细胞外表面的选择性。双标记方法进一步提供了证据,表明GLP-1R和GCGR分别与胰高血糖素和GLP-1存在交叉反应性,这在使用这两种多肽组合进行医学治疗的背景下具有重要意义。